• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-取代-N-(4-氧代-3-氧杂环丁烷基)N-酰基乙醇胺酸酰胺酶(NAAA)抑制剂的合成、构效关系及结构稳定性关系

Synthesis, structure-activity, and structure-stability relationships of 2-substituted-N-(4-oxo-3-oxetanyl) N-acylethanolamine acid amidase (NAAA) inhibitors.

作者信息

Vitale Romina, Ottonello Giuliana, Petracca Rita, Bertozzi Sine Mandrup, Ponzano Stefano, Armirotti Andrea, Berteotti Anna, Dionisi Mauro, Cavalli Andrea, Piomelli Daniele, Bandiera Tiziano, Bertozzi Fabio

机构信息

Drug Discovery & Development, Italian Institute of Technology (IIT), Via Morego 30, 16163 Genova (Italy).

出版信息

ChemMedChem. 2014 Feb;9(2):323-36. doi: 10.1002/cmdc.201300416. Epub 2014 Jan 8.

DOI:10.1002/cmdc.201300416
PMID:24403170
Abstract

N-Acylethanolamine acid amidase (NAAA) is a cysteine amidase that preferentially hydrolyzes saturated or monounsaturated fatty acid ethanolamides (FAEs), such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), which are endogenous agonists of nuclear peroxisome proliferator-activated receptor-α (PPAR-α). Compounds that feature an α-amino-β-lactone ring have been identified as potent and selective NAAA inhibitors and have been shown to exert marked anti-inflammatory effects that are mediated through FAE-dependent activation of PPAR-α. We synthesized and tested a series of racemic, diastereomerically pure β-substituted α-amino-β-lactones, as either carbamate or amide derivatives, investigating the structure-activity and structure-stability relationships (SAR and SSR) following changes in β-substituent size, relative stereochemistry at the α- and β-positions, and α-amino functionality. Substituted carbamate derivatives emerged as more active and stable than amide analogues, with the cis configuration being generally preferred for stability. Increased steric bulk at the β-position negatively affected NAAA inhibitory potency, while improving both chemical and plasma stability.

摘要

N-酰基乙醇胺酰胺酶(NAAA)是一种半胱氨酸酰胺酶,它优先水解饱和或单不饱和脂肪酸乙醇酰胺(FAE),如棕榈酰乙醇酰胺(PEA)和油酰乙醇酰胺(OEA),这些都是核过氧化物酶体增殖物激活受体-α(PPAR-α)的内源性激动剂。具有α-氨基-β-内酯环的化合物已被鉴定为强效和选择性NAAA抑制剂,并已显示出通过FAE依赖性激活PPAR-α介导的显著抗炎作用。我们合成并测试了一系列外消旋、非对映体纯的β-取代α-氨基-β-内酯,作为氨基甲酸酯或酰胺衍生物,研究了β-取代基大小、α和β位的相对立体化学以及α-氨基官能团变化后的构效关系和结构稳定性关系(SAR和SSR)。取代氨基甲酸酯衍生物比酰胺类似物更具活性和稳定性,顺式构型通常更有利于稳定性。β位空间位阻的增加对NAAA抑制效力有负面影响,同时提高了化学稳定性和血浆稳定性。

相似文献

1
Synthesis, structure-activity, and structure-stability relationships of 2-substituted-N-(4-oxo-3-oxetanyl) N-acylethanolamine acid amidase (NAAA) inhibitors.2-取代-N-(4-氧代-3-氧杂环丁烷基)N-酰基乙醇胺酸酰胺酶(NAAA)抑制剂的合成、构效关系及结构稳定性关系
ChemMedChem. 2014 Feb;9(2):323-36. doi: 10.1002/cmdc.201300416. Epub 2014 Jan 8.
2
Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.2-甲基-4-氧代-3-氧杂环丁基氨基甲酸酯类化合物的合成及构效关系研究,一类强效的 N-酰基乙醇胺水解酶(NAAA)抑制剂。
J Med Chem. 2013 Sep 12;56(17):6917-34. doi: 10.1021/jm400739u. Epub 2013 Aug 30.
3
N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships.N-(2-氧代-3-氧杂环丁基)氨基甲酸酯类作为 N-酰基乙醇胺酸酰胺酶抑制剂的合成及构效关系和构性关系研究。
J Med Chem. 2012 May 24;55(10):4824-36. doi: 10.1021/jm300349j. Epub 2012 May 10.
4
Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.设计和合成氰酰胺作为有效和选择性的 N-酰基乙醇胺酸酰胺酶抑制剂。
Bioorg Med Chem. 2020 Jan 1;28(1):115195. doi: 10.1016/j.bmc.2019.115195. Epub 2019 Nov 11.
5
Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.N-(2-氧代-3-恶唑烷基)酰胺的合成及构效关系研究作为 N-酰基乙醇胺水解酶抑制剂。
J Med Chem. 2010 Aug 12;53(15):5770-81. doi: 10.1021/jm100582w.
6
Advances in the discovery of N-acylethanolamine acid amidase inhibitors.N-酰基乙醇胺酸酰胺酶抑制剂的发现进展。
Pharmacol Res. 2014 Aug;86:11-7. doi: 10.1016/j.phrs.2014.04.011. Epub 2014 May 4.
7
Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.β-内酰胺类化合物作为N-酰基乙醇胺酸酰胺酶(NAAA)抑制剂的开发进展:新型强效N-O-取代衍生物的合成与构效关系研究
Eur J Med Chem. 2017 Jan 27;126:561-575. doi: 10.1016/j.ejmech.2016.11.039. Epub 2016 Nov 23.
8
Activity-Based Probe for N-Acylethanolamine Acid Amidase.基于活性的N-酰基乙醇胺酸酰胺酶探针。
ACS Chem Biol. 2015 Sep 18;10(9):2057-2064. doi: 10.1021/acschembio.5b00197. Epub 2015 Jun 23.
9
Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.鉴定高效的 N-酰基乙醇胺酸酰胺酶(NAAA)抑制剂:恶唑烷酮衍生物末端苯基部分的优化。
Eur J Med Chem. 2017 Oct 20;139:214-221. doi: 10.1016/j.ejmech.2017.08.004. Epub 2017 Aug 3.
10
3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.作为适合全身给药的N-酰基乙醇胺酸酰胺酶(NAAA)抑制剂的3-氨基氮杂环丁烷-2-酮衍生物。
ChemMedChem. 2014 Jul;9(7):1602-14. doi: 10.1002/cmdc.201300546. Epub 2014 May 14.

引用本文的文献

1
α-Acylamino-β-lactone -Acylethanolamine-hydrolyzing Acid Amidase Inhibitors Encapsulated in PLGA Nanoparticles: Improvement of the Physical Stability and Protection of Human Cells from Hydrogen Peroxide-Induced Oxidative Stress.包裹于聚乳酸-羟基乙酸共聚物纳米颗粒中的α-酰基氨基-β-内酯-酰基乙醇胺水解酸酰胺酶抑制剂:改善物理稳定性并保护人类细胞免受过氧化氢诱导的氧化应激
Antioxidants (Basel). 2022 Mar 31;11(4):686. doi: 10.3390/antiox11040686.
2
Molecular mechanism of activation of the immunoregulatory amidase NAAA.免疫调节酰胺酶 NAAA 的激活的分子机制。
Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10032-E10040. doi: 10.1073/pnas.1811759115. Epub 2018 Oct 9.
3
Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase.
基于活性的N-酰基乙醇胺酸酰胺酶探针的制备及其体内应用
J Vis Exp. 2016 Nov 23(117):54652. doi: 10.3791/54652.
4
Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α.一种新型N-酰基乙醇胺酸酰胺酶抑制剂F96通过过氧化物酶体增殖物激活受体α(PPAR-α)发挥的潜在镇痛作用。
Sci Rep. 2015 Aug 27;5:13565. doi: 10.1038/srep13565.
5
Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation.分别通过过氧化物酶体增殖物激活受体α(PPARα)和大麻素1型(CB1)受体机制抑制脂肪酸酰胺水解酶(FAAH)对大鼠急性恶心和预期性恶心的干扰:一种双重解离。
Psychopharmacology (Berl). 2015 Oct;232(20):3841-8. doi: 10.1007/s00213-015-4050-7. Epub 2015 Aug 23.
6
Activity-Based Probe for N-Acylethanolamine Acid Amidase.基于活性的N-酰基乙醇胺酸酰胺酶探针。
ACS Chem Biol. 2015 Sep 18;10(9):2057-2064. doi: 10.1021/acschembio.5b00197. Epub 2015 Jun 23.
7
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.N-棕榈酰乙醇胺与神经炎症:一种新型的溶解治疗策略。
Mol Neurobiol. 2015 Oct;52(2):1034-42. doi: 10.1007/s12035-015-9253-8. Epub 2015 Jun 9.
8
Endocannabinoids, related compounds and their metabolic routes.内源性大麻素、相关化合物及其代谢途径。
Molecules. 2014 Oct 24;19(11):17078-106. doi: 10.3390/molecules191117078.
9
3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.作为适合全身给药的N-酰基乙醇胺酸酰胺酶(NAAA)抑制剂的3-氨基氮杂环丁烷-2-酮衍生物。
ChemMedChem. 2014 Jul;9(7):1602-14. doi: 10.1002/cmdc.201300546. Epub 2014 May 14.
10
Advances in the discovery of N-acylethanolamine acid amidase inhibitors.N-酰基乙醇胺酸酰胺酶抑制剂的发现进展。
Pharmacol Res. 2014 Aug;86:11-7. doi: 10.1016/j.phrs.2014.04.011. Epub 2014 May 4.